ACCESSIBILITY

24/7

Headlines

18:02

Rapyd raises $500M at $4.5B valuation to complete $610M PayU acquisition

15:31

Where will US markets find their bottom? A model points to a potential 11% drop

14:58

Matrix looks to Wall Street: $2.1 billion merger could pave way for Nasdaq listing

14:14

IAI reports record $6.1 billion in sales as global demand for weapons surges

Buzz

Most popular

Daily

Weekly

"Eventually, AI will surpass us in everything"—so what skills will still matter?

Rapyd raises $500M at $4.5B valuation to complete $610M PayU acquisition

Sola Security aims to be the Wix of cyber with $30 million Seed round

AI startup D-ID lays off a quarter of its workforce just days after Microsoft deal

Michael Levitt Analysis: Corona Is Slowing Down, Humanity Will Survive

More news

Opioid

10 stories about Opioid

Why are investors so pleased about Teva's $4.35 billion opioid settlement?

27.07.22|Sophie Shulman

The settlement removes the cloud of uncertainty that hovered over Teva, which on the one hand prevented investors from placing trust in its stock, while on the other hand also prevented Teva management from making substantial moves

Teva reaches $4.35 billion settlement in U.S. opioid lawsuits, shares surge

27.07.22|Sophie Shulman and Reuters

Teva is set to pay state and local governments up to $3.7 billion in cash over 13 years plus a contribution of $1.2 billion worth of the opioid overdose reversal drug naloxone

Double trouble for Teva as NY State files charges on same day as DOJ

18.08.20|CTech

Governor Andrew M. Cuomo announced that the New York State Department of Financial Services has initiated administrative proceedings against Teva in connection with the Opioid Crisis

Teva Announces $23.25 Billion Opioid Abuse Settlement Agreement

22.10.19|Lilach Baumer

Teva announced on Monday a settlement with both Cuyahoga and Summit counties of Ohio, averting the trial scheduled for later that day, and an agreement in principle for a global settlement framework

Teva Makes $15 Billion Settlement Offer in U.S. Opioid Case, Report Says

16.10.19|Hezi Sternlicht

The Israeli drugmaker and several other drug distributors are set to face around 2,500 lawsuits related to the U.S. opioid abuse epidemic in just a week at a Cleveland, Ohio federal court

Judge Rejects Teva’s Request to Be Tried Separately in U.S. Opioid Case, Report Says

13.10.19|CTech

Teva made a last minute attempt to be tried separately in opioid abuse damages case set to be held on October 21 in federal court in Cleveland, Ohio

Court Approves One Teva Opioid Settlement, Many More to Come

25.06.19|Hezi Sternlicht

The settlement will see Teva will pay Oklahoma a one-time payment of $85 million to settle claims that it had played a role in exacerbating the U.S. opioid use epidemic there

Israel Leads OECD Countries on Opioid Use Increase, Says Report

19.05.19|Adrian Filut

Between 2011 and 2016, the availability of opioids in Israel grew by 125%, according to an OECD report published over the weekend

FDA Approves Teva’s Generic Nasal Spray for Opioid Overdose

21.04.19|Lilach Baumer

Commonly known as Narcan, the spray is considered a life-saving medication, and Teva’s drug is the first generic product approved that does not require medical training to use

Bidder Contests Teva Sale of Jerusalem Facility

31.03.19|Amitai Gazit and Lilach Baumer

Earlier this month, Teva agreed to sell the land tenure rights of its two Jerusalem factories, set to close by the end of 2019, for a combined $77 million